Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

10,562 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
[A case of juvenile pulmonary infarction associated with diet therapy].
Inoue T, Oida K, Taguchi Y, Tanaka E, Kato T, Sakuramoto M, Minakuchi M, Maeda Y, Maniwa K, Terada K, Noma S. Inoue T, et al. Among authors: kato t. Nihon Kokyuki Gakkai Zasshi. 2003 Mar;41(3):223-7. Nihon Kokyuki Gakkai Zasshi. 2003. PMID: 12772605 Japanese.
[A case of pulmonary Mycobacterium avium infection presenting multiple nodules with substantial difference in 18F-fluorodeoxyglucose uptake].
Sekine A, Hagiwara E, Ogura T, Shiihara J, Matsushima A, Tsuchiya N, Enomoto T, Shinohara T, Baba T, Tagawa A, Endo T, Sogo Y, Nishihira R, Komatsu S, Kato T, Takahashi H. Sekine A, et al. Among authors: kato t. Nihon Kokyuki Gakkai Zasshi. 2009 Jul;47(7):575-80. Nihon Kokyuki Gakkai Zasshi. 2009. PMID: 19637797 Japanese.
Pemetrexed and carboplatin followed by pemetrexed maintenance therapy in chemo-naïve patients with advanced nonsquamous non-small-cell lung cancer.
Okamoto I, Aoe K, Kato T, Hosomi Y, Yokoyama A, Imamura F, Kiura K, Hirashima T, Nishio M, Nogami N, Okamoto H, Saka H, Yamamoto N, Yoshizuka N, Sekiguchi R, Kiyosawa K, Nakagawa K, Tamura T. Okamoto I, et al. Among authors: kato t. Invest New Drugs. 2013 Oct;31(5):1275-82. doi: 10.1007/s10637-013-9941-z. Epub 2013 Mar 10. Invest New Drugs. 2013. PMID: 23475281 Clinical Trial.
Erlotinib alone or with bevacizumab as first-line therapy in patients with advanced non-squamous non-small-cell lung cancer harbouring EGFR mutations (JO25567): an open-label, randomised, multicentre, phase 2 study.
Seto T, Kato T, Nishio M, Goto K, Atagi S, Hosomi Y, Yamamoto N, Hida T, Maemondo M, Nakagawa K, Nagase S, Okamoto I, Yamanaka T, Tajima K, Harada R, Fukuoka M, Yamamoto N. Seto T, et al. Among authors: kato t. Lancet Oncol. 2014 Oct;15(11):1236-44. doi: 10.1016/S1470-2045(14)70381-X. Epub 2014 Aug 27. Lancet Oncol. 2014. PMID: 25175099 Clinical Trial.
A prospective, multicentre phase II trial of low-dose erlotinib in non-small cell lung cancer patients with EGFR mutations pretreated with chemotherapy: Thoracic Oncology Research Group 0911.
Yamada K, Aono H, Hosomi Y, Okamoto H, Kato T, Komase Y, Nishikawa M, Azuma K, Takeoka H, Okuma Y, Nakahara Y, Sato A, Oba MS, Morita S, Kunitoh H, Watanabe K. Yamada K, et al. Among authors: kato t. Eur J Cancer. 2015 Sep;51(14):1904-10. doi: 10.1016/j.ejca.2015.06.120. Epub 2015 Jul 11. Eur J Cancer. 2015. PMID: 26174465 Clinical Trial.
10,562 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page